Canada Cannabis News

Canada’s Aphria Inc. is purchasing SweetWater Brewing Co. — based in Atlanta, Georgia — for approximately USD $300 million.

Canada’s Aurora Cannabis reported a slight increase in 2021 Q1 revenue over the fourth quarter of last year.

Canadian researchers found that 43.5 percent of patients who started using medical cannabis to mitigate harmful alcohol consumption were able to reduce the frequency of their alcohol use.

A recent survey suggests that most Canadian cannabis consumers are not comfortable talking about their cannabis use with their parents.

Aurora Cannabis is facing a class-action lawsuit that alleges the company made “false and misleading statements” about its business, operational, and compliance policies.

Canada’s MediPharm and European pharmaceutical firm STADA have signed an exclusive supply agreement for the distribution of medical cannabis products in Germany.

Despite mass layoffs and losses exceeding $3 billion for the 2020 fiscal year, Aurora Cannabis executives received a 58 percent boost to their compensation awards — which totaled $9.8 million — and cash bonuses amounting to $700,000.

Canadian cannabis events company Lift & Co. filed for bankruptcy after its events-based cash flow dried up due to coronavirus restrictions.

The Canadian Automobile Association (CAA) has released a public education campaign that discourages teens and young adults from driving after eating cannabis-infused edibles.

A survey of Canadian cannabis users found 72% say they don’t fit the “stoner” stereotype commonly depicted in movies and TV.

Canada’s agriculture sector avoided the general economic decline caused by the COVID-19 pandemic because of a significant boost in cannabis sales.

Eight Canadian cannabis brands sent a joint letter to the Royal Canadian Mounted Police requesting law enforcement action against Weedmaps, who they say is hindering the legal industry by listing unlicensed dispensaries.

California cannabis company Vibe Bioscience is set to acquire Cathedral Asset Holding Corporation, a wholly-owned subsidiary of Ventura Cannabis and Wellness Corp.

The United States spent $1.49 billion on cannabis research between 2000 and 2018. Most of the funds were directed at understanding the potential harms of cannabis use.

More than half of all cannabis sales in Canada still take place in the unregulated marketplace despite having federally legalized almost two years ago.

Federal prosecutors in Canada have been directed to avoid prosecuting drug possession cases unless the crime poses a major public safety risk.

A recent study by the Ottowa Hospital in Ontario, Canada suggests that cannabis use during pregnancy can increase the risk of autism.

Canada’s Northwest Territories has reduced the price of cannabis products by 10 percent in hopes of curbing the unregulated market.

The Canadian Association of Chiefs of Police has issued a call for lawmakers to federally decriminalize the low-level possession of all drugs.

During the nearly two years of federal legalization in Canada, no single cannabis brand has earned more than 41 percent recognition among consumers.

Unlicensed cannabis producers in British Columbia earned about $1.24 billion last year, while licensed B.C. companies earned just $765 million.

Toronto-based Halo Labs, which serves consumers in both Canada and multiple U.S. state markets, reported a 49 percent decrease in revenue during the first quarter of 2020.

Florida medical cannabis company Bluma Wellness Inc. is now trading on the Canadian Securities Exchange under the BWEL.U symbol.

Health Canada says the cannabis industry has a generally high rate of compliance, having ordered just 15 product recalls — all due to mislabeled CBD and THC content — since legalizing in 2018.